Depression, suicide, and suicide prevention in schizophrenia

Suicide and Life-Threatening Behavior

Volumn 30, Issue 1, 2000, Pages 34-49

  Fenton, Wayne S ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; ZIPRASIDONE;

COMMUNITY CARE; COMORBIDITY; DEPRESSION; DISEASE COURSE; HIGH RISK PATIENT; HUMAN; MENTAL DISEASE; REVIEW; SCHIZOPHRENIA; SUICIDAL BEHAVIOR; SUICIDE; SYMPTOMATOLOGY;

COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE;

EID: 0034128178     PISSN: 03630234     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. ALLEBECK, P. (1989). Schizophrenia: A life-shortening disease. Schizophrenia Bulletin, 15, 81-88.
2. AMERICAN PSYCHIATRIC ASSOCIATION. (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington, DC: Author.
3. AMERICAN PSYCHIATRIC ASSOCIATION. (1997). Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154, (Suppl.) 1-63.
4. ANDREASEN, N. C., ARNDT, S., ALLIGER, R., MILLER, D., & FLAUM, M. (1995). Symptoms of schizophrenia: Methods, meanings and mechanisms. Archives of General Psychiatry, 52, 341-351.
5. ANGST, J. (1988). European follow-up studies of schizophrenia. Schizophrenia Bulletin, 14, 501-513.
6. ARNDT, S., ANDREASEN, N. C., FLAUM, M., MILLER, D., & NOPOULOS, P. (1995). A longitudinial study of symptom dimensions in schizophrenia: Prediction and patterns of change. Archives of General Psychiatry, 52, 352-360.
7. ARORA, R. C., & MELTZER, H. Y. (1989). Seritonergic measures in the brains of suicide victims and control subjects. American Journal of Psychiatry, 146, 730-736.
8. ASBURG, M. (1997). Neurotransmitters and suicidal behavior. Annals of the New York Academy of Sciences, 836, 158-181.
9. ASNIS, G. M., FRIEDMAN, T. A., SANDERSON, W. C., KAPLAN, M. L., VAN PRAAG, H. M., & HARKAVY-FRIEDMAN, J. M. (1993). Suicidal behaviors in adult psychiatric outpatients: I. Description and prevalence. American Journal of Psychiatry, 50, 108-112.
10. BARTELS, S. J., DRAKE, R. E., & MCHUGO, G. J. (1993). Alcohol abuse, depression and suicidal behavior in schizophrenia. American Journal of Psychiatry, 149, 394-395.
11. BLACK, D. W., WINOKUR, G., & WARRACK, G. (1985). Suicide in schizophrenia: The Iowa linkage study. Journal of Clinical Psychiatry, 46, 14-17.
12. BREIER, A., & ASTRACHAN, B. M. (1984). Characterization of schizophrenic patients who commit suicide. American Journal of Psychiatry, 141, 206-209.
13. BROWN, S. (1997). Excess mortality of schizophrenia: A meta-analysis. British Journal of Psychiatry, 171, 502-508.
14. CALDWELL, C. B., & GOTTESMAN, I. I. (1990). Schizophrenics kill themselves too. Schizophrenia Bulletin, 16, 571-586.
15. CALDWELL, C. B., & GOTTESMAN, I. I. (1992). Schizophrenia - a high risk factor for suicide: Clues to risk reduction. Suicide and Life-Threatening Behavior, 22, 479-493.
16. CARPENTER, W. T., Jr., BUCHANAN, R. W., KIRKPATRICK, B., TAMMINGA, C., & WOOD, F. (1993). Strong inference, theory testing, and the neuroanatomy of schizophrenia. Archives of General Psychiatry, 50, 825-831.
17. CARPENTER, W. T., Jr., HEINRICHS, D. W., & WAGMAN, A. M. I. (1988) Deficit and non-deficit forms of schizophrenia: The concept. American Journal of Psychiatry, 145, 578-583.
18. CHENG, K. K., LEUNG, C. M., LO, W. H., & LAM, T. H. (1990). Risk factors of suicide among schizophrenics. Acta Psychiatrica Scandinavica, 81, 220-224.
19. COHEN, L. J., TEST, M. A., & BROWN, R. L. (1990). Suicide and schizophrenia: Data from a prospective community treatment study. American Journal of Psychiatry, 147, 602-607.
20. COTTON, P. G., DRAKE, R. E., & GATES, C. (1985). Critical issues in suicide among schizophrenics. Hospital and Community Psychiatry, 36, 534-536.
21. DASSORI, A. M., MEZZICH, J. E., & KESHAVAN, M. (1990). Suicidal indicators in schizophrenia. Acta Psychiatrica Scandinavica, 81, 409-413.
22. DINGMAN, C. W., & MCGLASHAN, T. H. (1986). Discriminating characteristics of suicide: Chestnut Lodge sample including patients with affective disorder, schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica, 74, 91-97.
23. DRAKE, R. E., & EHRLICH, J. (1985). Suicide attempts associated with akathesia. American Journal of Psychiatry, 142, 499-501.
24. DRAKE, R. E., GATES, C., COTTON, P. G., & WHITAKER, A. (1984). Suicide among schizophrenics: Who is at risk? Journal of Nervous and Mental Diseases, 172, 613-617.
25. DRAKE, R. E., GATES, C., WHITAKER, A., & COTTON, P. G. (1985). Suicide among schizophrenics: A review. Comprehensive Psychiatry, 26, 90-100.
26. FOIGHNER, J. P., ROBINS, E., GUZE, S. B., WOODRUFF, R. A., Jr., WINOKUR, G., & MUNOZ, R. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26(1), 57-63.
27. FENTON, W. S., & MCGLASHAN, T. H. (1991a). Natural history of schizophrenia subtypes I. Longitudinal course of paranoid, hebephrenic, and undifferentiated schizophrenia. Archives of General Psychiatry, 48, 969-977.
28. FENTON, W. S., & MCGLASHAN, T. H. (1991b). Natural history of schizophrenia subtypes: II. Positive and negative symptoms and long-term course. Archives of General Psychiatry, 48, 978-998.
29. FENTON, W. S., & MCGLASHAN, T. H. (1992). Testing systems for assessment of negative symptoms in schizophrenia. Archives of General Psychiatry, 49, 179-184.
30. FENTON, W. S., & MCGLASHAN, T. H. (1994). Antecedents, symptom progression, and long-term outcome of the deficit syndrome. American Journal of Psychiatry, 151, 351-356.
31. FENTON, W. S., MCGLASHAN, T. H., VICTOR, B. J., & BLYLER, C. R. (1997). Symptoms, subtype and suicidality in patients with schizophrenia spectrum disorders. American Journal of Psychiatry, 154, 199-204.
32. FENTON, W. S., MOSHER, L. R., HERRELL, J. M., & BLYLER, C. R. (1998). Randomized clinical trial of general hospital and residential alternative care for patients with severe and persistant mental illness. American Journal of Psychiatry, 155, 516-522.
33. FENTON, W. S., WYATT, R. J., & MCGLASHAN, T. H. (1994). Risk factors for spontaneous dyskinesia in schizophrenia. Archives of General Psychiatry, 51, 643-650.
34. FRANCES, A., DOCHERTY, J. P., & KAHN, D. A. (1996). The expert consensus guideline series: Treatment of schizophrenia. Journal of Clinical Psychiatry, 57, (suppl. 12B), 1-58.
35. GOLDSTEIN, J. M., SANTANGELO, S. L., SIMPSON, J., & TSUANG, M. T. (1993). Gender and mortality in schizophrenia: Do women act like men? Psychological Medicine, 23, 941-948.
36. GOLDSTEIN, R. B., BLACK, D. W., NASRALLAH, A., & WINOKUR, G. (1991) The prediction of suicide: Sensitivity, specificity and predictive value of a multivariate model applied to suicide among 1906 patients with affective disorders. Archives of General Psychiatry, 48, 418-422.
37. GROVE, W. M., & ANDREASEN, N. C. (1982). Simultaneous tests of multiple hypotheses in exploratory research. Journal of Nervous and Mental Disease, 170, 3-8.
38. HANSEN, T. E., CASEY, D. E., & HOFFMAN, W. F. (1997). Neuroleptic intolerance. Schizophrenia Bulletin, 23, 567-582.
39. HARKAVY-FRIEDMAN, J. M., & NELSON, E. (1997). Management of the suicidal patient with schizophrenia. Psychiatric Clinics of North America, 20, 625-639.
40. HEILA, H., ISOMETSA, E. T., HENRIKSSON, M. M., HEIKKINEN, M. E., MARTTUNEN, M. J., & LONNQVIST, J. K. (1997). Suicide and schizophrenia: A nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. American Journal of Psychiatry, 154, 1235-1242.
41. HEILA, H., ISOMETSA, E. T., HENRIKSSON, M. M., HEIKKINEN, M. E., MARTTUNEN, M. J., & LONNQVIST, J. K. (1998). Antecedents of suicide in people with schizophrenia. British Journal of Psychiatry, 173, 330-333.
42. JOBES, D. A., CASEY, J. O., BERMAN, A. L., & WRIGHT, D. G. (1991). Empirical criteria for the determination of suicide manner of death. Journal of Forensic Science, 36, 244-256.
43. JUDD, L. L. (1998, February). Mood disorders in schizophrenia: Epidemiology and comorbidity. Journal of Clinical Psychiatry (Monograph), 16, 2-4.
44. KANE, J. M., & MCGLASHAN, T. H. (1995). Treatment of schizophrenia. Lancet, 346, 820-825.
45. KAPLAN, K. J., & HARROW, M. (1996). Positive and negative symptoms as risk factors for later suicidal activity in schizophrenics versus depressives. Suicide and Life-Threatening Behavior, 26, 105-121.
46. KENDLER, K. S., KARKOWSKI, L. M., & WALSH, D. (1998). The structure of psychosis: Latent class analysis of probands from Roscommon Family Study. Archives of General Psychiatry, 55, 492-499.
47. KESSLER, R. C., MCGONAGLE, K. A., ZHAO, S., NELSON, C. B., HUGHES, M., ESHLEMAN, S., WITTCHEN, H. O., & KENDLER, K. S. (1994). Lifetime and 12 month prevalence of DSM III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.
48. KIRKPATRICK, B., BUCHANAN, R. W., BREIER, A., & CARPENTER, W. T., Jr. (1994). Depressive symptoms and the deficit syndrome of schizophrenia. Journal of Nervous and Mental Disorders, 182, 452-455.
49. KRAEPLIN, E. (1971). Dementia praecox and paraphrenia. Melbourne, FL: Robert E. Krieger Publishing.
50. KRAMER, M. S., VOGEL, W. H., DIJOHNSON, C., DEWEY, D. A., SHEVES, P., CAVICCHIA, S., LITTLE, P., SCHMIDT, R., & KIMES, I. (1989). Antidepressants in "depressed" schizophrenic inpatients: A controlled trial. Archives of General Psychiatry, 46, 922-928.
51. LEHMAN, A. F., STEINWACHS, D. M., & The Survey Co-Investigators of the PORT Project. (1998). Patterns of usual care for schizophrenia: Initial results from the schizophrenia Patient Outcomes Research Team (PORT) client survey. Schizophrenia Bulletin, 24, 11-20.
52. LICHT, R. W., MORTENSEN, P. B., GOULIAEV, G., & LUND, J. (1993). Mortality in Danish psychiatric long-stay patients, 1972-82. Acta Psychiatrica Scandinavica, 87, 336-341.
53. MARDER, S. R., DAVIS, J. M. & CHOUINARD, G. (1997). The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. Journal of Clinical Psychiatry, 58, 538-546.
54. MCGLASHAN, T. H. (1984a). The Chestnut Lodge Follow-Up Study: I. Follow-up methodology and study sample. Archives of General Psychiatry, 41, 573-585.
55. MCGLASHAN, T. H. (1984b). The Chestnut Lodge Follow-Up Study: II. Long-term outcome of schizophrenia and the affective disorders. Archives of General Psychiatry, 41, 586-601.
56. MCGLASHAN, T. H. (1988). A selective review of recent long-term follow-up studies of schizophrenia. Schizophrenia Bulletin, 14, 515-542.
57. MCGLASHAN, T. H., & CARPENTER, W. T., Jr. (1976). Post-psychotic depression in schizophrenia. Archives of General Psychiatry, 33, 231-239.
58. MCGLASHAN, T. H., & FENTON, W. S. (1993). Subtype progression and pathophysiologic deterioration in early schizophrenia. Schizophrenia Bulletin, 19, 71-84.
59. MELTZER, H. Y. (1998). Suicide in schizophrenia: Risk factors and clozapine treatment. Journal of Clinical Psychiatry, 59, (suppl. 3), 15-20.
60. MELTZER, H. Y. & OKAYLI, G. (1995). Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: Impact on risk-benefit assessment. American Journal of Psychiatry, 152, 183-190.
61. MILES, C. P. (1977). Conditions predisposing to suicide: A review. Journal of Nervous and Mental Disease, 164, 231-246.
62. MILLER, L., & FINNERTY, M. (1996). Sexuality, pregnancy and childrearing among women with schizophrenia spectrum disorders. Psychiatric Services, 47, 502-505.
63. MODESTIN, J., & HOFFMAN, H. (1989). Completed suicides in psychiatric inpatients and former inpatients. Acta Psychiatrica Scandinavica, 79, 229-234.
64. MORTENSON, P. B., & JUEL, K. (1993). Mortality and causes of death in first admitted schizophrenic patients. British Journal of Psychiatry, 163, 183-189.
65. MUNK-JORGENSEN, P., & MORTENSEN, P. B. (1992). Incidence and other aspects of the epidemiology of schizophrenia in Denmark, 1971-87. British Journal of Psychiatry, 161, 489-495.
66. MURPHY, G. E. (1983). On suicide prediction and prevention. Archives of General Psychiatry, 40, 343-344.
67. NIETO, E., VIETA, E., GASTO, C., VALLEJO, J., & CIRERA, E. (1992). Suicide attempts of high medical seriousness in schizophrenic patients. Comprehensive Psychiatry, 6, 384-387.
68. NYMAN, A. K., & JONSSON, H. (1986). Patterns of self-destructive behaviour in schizophrenia. Acta Psychiatrica Scandinavica, 73, 252-262.
69. RAKO, S., & MAZER, H. (Ed.). (1980). Semrad: The heart of a therapist. New York: Aronson.
70. RHODE, A., MANEROS, A., & DEISTER, A. (1988). Suicidal behavior in schizophrenia patients: A follow-up investigation. In S. D. Platt & N. Kreitman (eds.), Current research on suicide and parasuicide (pp. 78-97). Edinburgh: Edinburgh University Press.
71. ROBINS, L. N., & REGIER, D. A. (1991). Psychiatric disorders in America: The epidemiological catchment area study. New York: Free Press.
72. ROSSAU, C. D., & MORTENSEN, P. B. (1997). Risk factors for suicide in patients with schizophrenia: Nested case-control study. British Journal of Psychiatry, 171, 355-359.
73. ROY, A. (1982). Suicide in chronic schizophrenia. British Journal of Psychiatry, 141, 171-177.
74. ROY, A. (1986a). Depression, attempted suicide and suicide in patients with chronic schizophrenia. Psychiatric Clinics of North America, 9, 193-206.
75. ROY, A. (1986b) Suicide in schizophrenia. In A. Roy (Ed.), Suicide (pp. 97-112). Baltimore, MD: Williams & Wilkins.
76. ROY, A. (1992). Suicide in schizophrenia. International Review of Psychiatry, 4, 205-209.
77. SHNEIDMAN, E. S. (1989). Suicide: A multidimensional approach. In D. Jacobs & H. N. Brown (Eds.), Suicide: Understanding and responding (pp. 15-30). Madison, CT: International Universities Press.
78. SIRUS, S. G. (1991). Diagnosis of secondary depression in schizophrenia: Implications for DSM IV. Schizophrenia Bulletin, 17, 75-98.
79. SIRUS, S. G., VAN KAMMEN, D. P., & DOCHERTY, J. P. (1978). Use of antidepressant drugs in schizophrenia. Archives of General Psychiatry, 35, 1368-1377.
80. SLEDGE, W. H., TEBES, J., RAKFELDT, J., DAVIDSON, L., LYONS, L., & DRUSS, B. (1996). Day hospital/crisis respite care versus inpatient care: Part 1. Clinical outcomes. American Journal of Psychiatry, 153, 1065-1073.
81. STEPHENS, J. H. (1978). Long-term prognosis and follow-up in schizophrenia. Schizophrenia Bulletin, 4, 25-47.
82. STROUL, B. A. (1988). Residential crisis services: A review. Hospital and Community Psychiatry, 38, 1091-1095.
83. TAIMINEN, T. J., & KUJARI, H. (1994). Antipsychotic medication and suicide risk among schizophrenic and paranoid inpatients: A controlled retrospective study. Acta Psychiatrica Scandinavica, 90, 247-251.
84. TANDON, R., HARRIGAN, E., & ZORN, S. H. (1997). Ziprasidone: A novel antipsychotic with unique pharmacology and theraputic potential. Journal of Seritonin Research, 4, 159-177.
85. TOLLEFSON, G. D., SANGER, T. M., LU, Y., & THIEME, M. E. (1998) Depressive signs and symptoms in schizophrenia: A prospective blinded trial of olanzapine and haloperidol. Archives of General Psychiatry, 55, 250-258.
86. TSUANG, M. T., LYONS, M. J., & FARONE, S. V. (1990). Heterogeneity of schizophrenia. Conceptual models and analytic strategies. British Journal of Psychiatry, 156, 17-26.
87. TSUANG, M. T., WOOLSON, R. F., & FLEMING, J. A. (1980). Premature deaths in schizophrenia and affective disorders: An analysis of survival curves and variables affecting the shortened survival. Archives of General Psychiatry, 37, 979-983.
88. VIRKKUNEN, M. (1976). Attitude to psychiatric treatment before suicide in schizophrenia and paranoid psychosis. British Journal of Psychiatry, 128, 47-49.
89. WALKER, A. M., LANZA, L. L., ARELLANO, F., & ROTHMAN, K. J. (1997). Mortality in current and former users of clozapine. Epidemiology, 8, 671-677.
90. WESTERMEYER, J. F., HARROW, M., & MARENGO, J. T. (1991). Risk for suicide in schizophrenia and other psychotic and non-psychotic disorders. Journal of Nervous and Mental Disease, 179, 259-266.